A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer.
Nakai Y, Isayama H, Saito K, Sasaki T, Takahara N, Hamada T, Mizuno S, Miyabayashi K, Yamamoto K, Mohri D, Kogure H, Yamamoto N, Hirano K, Ijichi H, Tateishi K, Tada M, Koike K.
Nakai Y, et al. Among authors: yamamoto n, yamamoto k.
Cancer Chemother Pharmacol. 2014 Nov;74(5):911-5. doi: 10.1007/s00280-014-2563-0. Epub 2014 Aug 21.
Cancer Chemother Pharmacol. 2014.
PMID: 25143299
Clinical Trial.